Fortis Healthcare Ltd stock (INE061F01013): Share price dips 1.41% to 922 INR

Fortis Healthcare Ltd shares fell 1.41% to 922 INR on the National Stock Exchange of India, amid ongoing operations in India's healthcare sector. The company maintains a market cap of around ?68,448 crores with key metrics like ROE at 5.51%.

Fortis Healthcare Ltd shares declined 1.41% to close at 922 INR on the National Stock Exchange of India, according to NSE as of recent trading. This movement reflects activity in the Indian healthcare provider's stock, which operates a network of hospitals delivering secondary, tertiary, and quaternary care services.

As of: 14.05.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: Fortis Healthcare Limited
• Sector/industry: Health Care Providers & Services
• Headquarters/country: Gurugram, India
• Core markets: India
• Key revenue drivers: Hospital services, quaternary care
• Home exchange/listing venue: National Stock Exchange of India (FORTIS)
• Trading currency: INR

Fortis Healthcare Ltd: core business model

Fortis Healthcare Ltd, established in 1995, is an integrated healthcare provider headquartered in Gurugram, India. The company focuses on a wide range of medical services across its hospital network, including secondary, tertiary, and quaternary care, according to StockeZee company profile. With approximately 12,237 employees, it plays a key role in India's growing healthcare infrastructure.

The business model centers on operating multi-specialty hospitals that cater to diverse patient needs, from routine treatments to advanced procedures. This structure positions Fortis Healthcare Ltd as a significant player in the Health Care Equipment & Services group.

Main revenue and product drivers for Fortis Healthcare Ltd

Fortis Healthcare Ltd generates revenue primarily through its hospital operations in India. Key financial metrics include a market capitalization of ?68,448.28 crores, P/E ratio of 68.17, ROE of 5.51%, ROCE of 12.00%, and dividend yield of 0.12%, as reported by StockeZee as of recent data. EPS stands at ?13.43, with debt-to-equity at 0.28.

Hospital services, including specialized care in areas like cardiology, form the core revenue drivers. The company's presence in the competitive Indian market supports steady demand amid rising healthcare needs.

Industry trends and competitive position

The Indian healthcare sector is expanding rapidly, driven by population growth and increasing access to medical services. Fortis Healthcare Ltd competes with peers like Aster DM Healthcare and Narayana Hrudayalaya, holding a mid-cap status with its ?68,448 crore market cap, per StockeZee metrics. Industry lists highlight it among top hospital stocks.

Why Fortis Healthcare Ltd matters for US investors

Fortis Healthcare Ltd offers US investors exposure to India's booming healthcare market, one of the fastest-growing globally. With its listing on the NSE and ADR potential, it provides diversification into emerging market health services relevant to global portfolios tracking demographic shifts.

Conclusion

Fortis Healthcare Ltd continues to operate as a key player in India's healthcare landscape, with recent share price activity at 922 INR on NSE reflecting market dynamics. Financial metrics like 5.51% ROE and 0.12% dividend yield provide a snapshot of its position. US investors may note its role in the expanding sector, though volatility in emerging markets persists.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.